8.2 Controlled Substance Inventory Requirements (Initial, Biennial, Count Exactness)

8.2 Controlled Substance Inventory Requirements (Initial, Biennial, Count Exactness)

A fundamental element of DEA oversight and accountability under the Controlled Substances Act (CSA) is the mandatory controlled substance inventory. Inventories serve as the legal accounting baseline against which all receipts, distributions, and dispensings are audited. Regulations governing inventory taking, frequency, count exactness, and recordkeeping are codified in 21 CFR § 1304.11.

---

Initial Inventory Requirements

Before a pharmacy opens for business or begins handling controlled substances under a new DEA registration, an Initial Inventory must be conducted.

Key Initial Inventory Mandates:

• Timing: Conducted on the first day the pharmacy opens for business or handles controlled substances.
• Zero Stock Rule: Even if the pharmacy has zero controlled substances in stock on day one, an initial inventory document must be completed reflecting a zero count.
• Required Elements: The record must state the date, time of day (Opening of Business [AOB] or Close of Business [COB]), pharmacy name, DEA registration number, address, and signature of the person(s) taking the inventory.

---

Biennial Inventory Requirements

Following the initial inventory, every DEA registrant must conduct a complete controlled substance inventory at least every two years (biennially).

Timing & Frequency Rules:

• 2-Year Window: The biennial inventory can be taken on any date within two years of the previous inventory date.
• AOB vs. COB Mandate: The inventory record must explicitly state whether the count was performed at the Opening of Business (AOB) or Close of Business (COB) on the specified inventory date. This distinction ensures precise transaction matching for drugs dispensed or received on that calendar date.
• State Specifics: Many states mandate annual (every 1 year) inventories rather than federal biennial (every 2 years) inventories. Pharmacists must adhere to the stricter state requirement for compliance, but federal law sets the baseline at 2 years.

---

Newly Scheduled Drugs

When a previously non-controlled drug is placed into any controlled substance schedule (Schedules I through V) by the DEA, or when a controlled drug is reclassified to a higher schedule:

• Every registrant in possession of that drug must take an inventory of all on-hand stock of that specific substance on the effective date of scheduling.
• This newly scheduled inventory record is retained alongside existing inventory records and incorporated into future biennial inventories.

---

Count Exactness Rules: Exact vs. Estimated Counts

Federal law establishes strict standards regarding whether a pharmacist must perform an exact physical count or may use an estimated count during an inventory. The count exactness rule depends on the controlled substance schedule and the original commercial container size.

Deep Dive into the 1,000-Unit Threshold

On the MPJE, a common trap involves open bottles of Schedule III-V medications. If an open stock bottle of alprazolam 1 mg originally held 1,000 tablets, the pharmacist may estimate the count. However, if the open bottle originally held 1,001 or more tablets (e.g., a bulk container of 5,000 tablets), an exact physical count is required by federal law.

---

Required Content of Inventory Records

Every controlled substance inventory record maintained by a pharmacy must contain the following mandatory data fields:

1. Date the inventory was taken.
2. Time of day executed: Explicitly marked as Opening of Business (AOB) or Close of Business (COB).
3. Drug Name: Generic or brand name.
4. Dosage Form and Strength: (e.g., Oxycodone 10 mg tablet, Fentanyl 25 mcg/hr patch).
5. Number of Commercial Containers: (e.g., 3 unopened bottles, 1 opened bottle).
6. Quantity/Count per Container: Exact count for CIIs and large CIII-CV containers; estimated count for small CIII-CV open containers.
7. Total Quantity: Sum of units on hand.
8. Administrative Details: Pharmacy name, address, DEA number, and recommended signature of the pharmacist conducting the inventory.

---

Storage, Maintenance, and Retention Rules

• Retention Period: Inventory records must be maintained for a minimum of 2 years from the date of execution under federal law (21 CFR § 1304.04). State law may require 3 to 5 years.
• Separation of Schedule II Records: Inventory records for Schedule II controlled substances must be kept completely separate from all other pharmacy records.
• Schedule III-V Records: Records for Schedule III, IV, and V substances may be kept separately or maintained in such a form that they are readily retrievable (e.g., stamped with a red 'C' if interfiled, or accessible via distinct computer code).
• Central Recordkeeping Exclusions: While the DEA permits central storage for certain financial and shipping records, controlled substance inventories CANNOT be stored at a central location—they must be kept physically at the registered pharmacy location.